Optec International, Inc. OPTI
Set alert
0.00 USD 0.00 -11.76%
At close · Oct 30
0.0014 Day range 0.0016
0.0002 52-week range 0.003
- YTD
- +15.38%
- 1 year
- +15.38%
- Open
- 0.0016
- Prev close
- 0.0017
- Mkt cap
- 7.12M
- Vol
- 2.60M
- Avg vol
- 3.26M
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0014
- High
- 0.0016
3M chart
Signals (29)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 2026 | 2 days ago |
| SMA: Bearish | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 28, 2026 | 3 days ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
Financials — quick view
OPTI Revenue — quarterly 0
OPTI Net income — quarterly -506.00K
OPTI EPS — quarterly -0.04
News
- Optimi Health to Present at the ThinkEquity Conference
- Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply
- Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
- Optimi Health Establishes Discretionary Equity Facility
- Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
- Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
- Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
- Diamond Equity Research Initiates Coverage on Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN)
- Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date
- Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
Your note
Sign in to keep a note on OPTI — it syncs with the Stock Master app.